Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-Mâ„¢ adjuvant, today ...
Novavax, Inc. ( NASDAQ:NVAX ) investors will be delighted, with the company turning in some strong numbers with ...
The MHRA has approved Novavax’s updated Nuvaxovid vaccine for the latest subvariant in individuals aged 12 and older. This ...
On Wednesday, Novavax Inc (NVAX) stock saw a decline, ending the day at $7.76 which represents a decrease of $-0.70 or -8.27% from the prior close of $8.46. The stock opened at $8.44 and touched a low ...
Politics will matter greatly for the biotechnology and healthcare sectors. On Thursday, President-elect Trump said that ...
Wall Street is absorbing a jump in retail sales and Jerome Powell's hawkish comments as Trump-fueled optimism starts to wear ...
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to ...
Shares of several vaccine makers including Pfizer and Astrazeneca were down Friday morning following the nomination of Robert ...
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX ...
Vaccine stocks continued to fall in premarket trading on Friday, following a sharp decline on Thursday after President-elect Donald Trump announced he would appoint Robert F. Kennedy Jr. to head the ...
Vaccine stocks continued to fall in premarket trading on Friday, following a sharp decline on Thursday, after President-elect Donald Trump announced he would appoint Robert F. Kennedy Jr. to head the ...
The immediate aftermath of the nomination saw vaccine stock prices drop on account of Kennedy’s well-publicized views on ...